SCHEMBL29930815

SCHEMBL29930815

COc1cccc(-c2nn(COCC[Si](C)(C)C)c3ncc(Br)cc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.41
TYRO3 Q06418 1/20 0.41
MERTK Q12866 1/20 0.41
MAOB P27338 1/20 0.37
DGAT1 O75907 2/20 0.36
DGAT2 Q96PD7 3/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
HSD17B10 Q99714 4/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 2/20 0.35
USP2 O75604 2/20 0.35
CLK1 P49759 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930779 0.90 AXL (0.41) AXLTYRO3MERTKDGAT1SMN1; SMN2
SCHEMBL1592834 0.88 MERTK (0.39) AXLTYRO3MERTKDGAT1ALDH1A1
SCHEMBL29930407 0.87 DYRK1B (0.39) AXLTYRO3MERTKDGAT1PDE1B
SCHEMBL29930401 0.85 DYRK1B (0.40) AXLMERTKDGAT1SRCKDR
SCHEMBL29930863 0.84 DYRK1B (0.47) AXLTYRO3MERTKHSD17B10ALDH1A1
SCHEMBL29930812 0.83 PDE4A (0.39) ALDH1A1MAPTKDM4EKMT2AMEN1
SCHEMBL29930809 0.83 DGAT1 (0.37) AXLMERTKDGAT1SMN1; SMN2ALDH1A1
SCHEMBL29930508 0.82 DGAT1 (0.36) MERTKDGAT1MAPTPDE1BDYRK1B
SCHEMBL29930954 0.82 DYRK1A (0.46) NPSR1KDM4EPDE1BDYRK1B
SCHEMBL3375894 0.81 DGAT1 (0.40) AXLTYRO3MERTKMAOBDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed